An Autoimmune Disease-Associated CTLA-4 Splice Variant Lacking the B7 Binding Domain Signals Negatively in T Cells
- 1 May 2004
- Vol. 20 (5) , 563-575
- https://doi.org/10.1016/s1074-7613(04)00110-4
Abstract
No abstract availableKeywords
Funding Information
- Merck Genome Research Institute
- Juvenile Diabetes Research Foundation United States of America
- Wellcome Trust
- National Institutes of Health (NMSS RG 2571, NS35685, POI AI 39671, ROI AI4480)
This publication has 32 references indexed in Scilit:
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- Negative Regulation of T Cell Receptor–Lipid Raft Interaction by Cytotoxic T Lymphocyte–associated Antigen 4The Journal of Experimental Medicine, 2003
- Polymorphism of the CTLA-4 Gene Is Associated with Autoimmune Hypothyroidism in the United KingdomThyroid®, 2002
- A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22Nature Genetics, 1996
- Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR EngagementPublished by Elsevier ,1996
- CTLA-4 ligation blocks CD28-dependent T cell activation.The Journal of Experimental Medicine, 1996
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.The Journal of Experimental Medicine, 1996
- Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4Science, 1996
- An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitisImmunity, 1995
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994